Lincomycin Oral Capsules/Tablets bulk supplier for pharma manufacturers

Lincomycin Oral Capsules/Tablets 250mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Capsules/Tablets

Available Strengths: 250mg, 500 mg

Reference Brands: Lincocin (US)

Lincomycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide elongation. It effectively treats severe Gram-positive infections, such as skin and soft tissue infections. Benefits include rapid bacterial eradication, high efficacy against resistant strains, and oral administration for outpatient care when used appropriately.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Lincomycin capsules and tablets are approved in the EU and US for treating severe Gram-positive infections, including skin, soft tissue, and bone infections. In the EU, brands like Lincocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data, with generic formulations available. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We ensure seamless market access for lincomycin formulations, adhering to European and US standards for safe, effective antibacterial therapy.

Lincomycin Oral Capsules/Tablets — third party manufacturing & bulk supply

Lincomycin Oral Capsules/Tablets 250mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lincomycin Oral Capsules/Tablets is supplied as Oral Capsules/Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lincomycin Oral Capsules/Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lincomycin Oral Capsules/Tablets →

Back to Listing

Frequently Asked Questions

Lincomycin Oral Capsules/Tablets is listed as Oral Capsules/Tablets in 250mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Lincomycin Oral Capsules/Tablets is referenced against Lincocin (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.